200 related articles for article (PubMed ID: 15005788)
1. Role of routine ultrasonography in monitoring the outcome of medical abortion in a clinical setting.
Acharya G; Haugen M; Bråthen A; Nilsen I; Maltau JM
Acta Obstet Gynecol Scand; 2004 Apr; 83(4):390-4. PubMed ID: 15005788
[TBL] [Abstract][Full Text] [Related]
2. Parity is a major determinant of success rate in medical abortion: a retrospective analysis of 3161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost.
Bartley J; Tong S; Everington D; Baird DT
Contraception; 2000 Dec; 62(6):297-303. PubMed ID: 11239616
[TBL] [Abstract][Full Text] [Related]
3. Timing and indication for curettage after medical abortion in early pregnant women with prior uterine incision.
Wang G; Li D; Manconi F; Dong B; Zhang Y; Sun B
Contraception; 2010 Jan; 81(1):62-6. PubMed ID: 20004275
[TBL] [Abstract][Full Text] [Related]
4. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
Guest J; Chien PF; Thomson MA; Kosseim ML
BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
[TBL] [Abstract][Full Text] [Related]
5. A medical approach to management of spontaneous abortion using misoprostol. Extending misoprostol treatment to a maximum of 48 hours can further improve evacuation of retained products of conception in spontaneous abortion.
Chung T; Leung P; Cheung LP; Haines C; Chang AM
Acta Obstet Gynecol Scand; 1997 Mar; 76(3):248-51. PubMed ID: 9093140
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for unsuccessful medical abortion with mifepristone and misoprostol.
Haimov-Kochman R; Arbel R; Sciaky-Tamir Y; Brzezinski A; Laufer N; Yagel S
Acta Obstet Gynecol Scand; 2007; 86(4):462-6. PubMed ID: 17486469
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of suction curettage and mifepristone abortion in the United States. A prospective comparison study.
Jensen JT; Astley SJ; Morgan E; Nichols MD
Contraception; 1999 Mar; 59(3):153-9. PubMed ID: 10382077
[TBL] [Abstract][Full Text] [Related]
8. Sonographic appearance of the uterine cavity following administration of mifepristone and misoprostol for termination of pregnancy.
Markovitch O; Tepper R; Klein Z; Fishman A; Aviram R
J Clin Ultrasound; 2006; 34(6):278-82. PubMed ID: 16788959
[TBL] [Abstract][Full Text] [Related]
9. Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion.
Baird DT; Sukcharoen N; Thong KJ
Hum Reprod; 1995 Jun; 10(6):1521-7. PubMed ID: 7593528
[TBL] [Abstract][Full Text] [Related]
10. Ability of the clinician and patient to predict the outcome of mifepristone and misoprostol medical abortion.
Rossi B; Creinin MD; Meyn LA
Contraception; 2004 Oct; 70(4):313-7. PubMed ID: 15451336
[TBL] [Abstract][Full Text] [Related]
11. The abortifacient effect of misoprostol in the second trimester. A randomized comparison with gemeprost in patients pre-treated with mifepristone (RU486).
el-Refaey H; Hinshaw K; Templeton A
Hum Reprod; 1993 Oct; 8(10):1744-6. PubMed ID: 8300840
[TBL] [Abstract][Full Text] [Related]
12. Double-blind randomized trial of mifepristone in combination with vaginal gemeprost or misoprostol for induction of abortion up to 63 days gestation.
Bartley J; Brown A; Elton R; Baird DT
Hum Reprod; 2001 Oct; 16(10):2098-102. PubMed ID: 11574498
[TBL] [Abstract][Full Text] [Related]
13. Medical abortion outcomes after a second dose of misoprostol for persistent gestational sac.
Reeves MF; Kudva A; Creinin MD
Contraception; 2008 Oct; 78(4):332-5. PubMed ID: 18847584
[TBL] [Abstract][Full Text] [Related]
14. Can women accurately assess the outcome of medical abortion based on symptoms alone?
Jackson AV; Dayananda I; Fortin JM; Fitzmaurice G; Goldberg AB
Contraception; 2012 Feb; 85(2):192-7. PubMed ID: 22067786
[TBL] [Abstract][Full Text] [Related]
15. Simplified medical abortion screening: a demonstration project.
Raymond EG; Tan YL; Comendant R; Sagaidac I; Hodorogea S; Grant M; Sanhueza P; Van Pratt E; Gillespie G; Boraas C; Weaver MA; Platais I; Bousieguez M; Winikoff B
Contraception; 2018 Apr; 97(4):292-296. PubMed ID: 29170088
[TBL] [Abstract][Full Text] [Related]
16. Induction of therapeutic abortion in early pregnancy with mifepristone in combination with prostaglandin pessary.
Rodger MW; Baird DT
Lancet; 1987 Dec; 2(8573):1415-8. PubMed ID: 2891991
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for surgical intervention of early medical abortion.
Meaidi A; Friedrich S; Gerds TA; Lidegaard O
Am J Obstet Gynecol; 2019 May; 220(5):478.e1-478.e15. PubMed ID: 30763542
[TBL] [Abstract][Full Text] [Related]
18. Alternatives to a routine follow-up visit for early medical abortion.
Clark W; Bracken H; Tanenhaus J; Schweikert S; Lichtenberg ES; Winikoff B
Obstet Gynecol; 2010 Feb; 115(2 Pt 1):264-272. PubMed ID: 20093898
[TBL] [Abstract][Full Text] [Related]
19. Predictors of uterine evacuation following early medical abortion with mifepristone and misoprostol.
Reeves MF; Monmaney JA; Creinin MD
Contraception; 2016 Feb; 93(2):119-25. PubMed ID: 26285178
[TBL] [Abstract][Full Text] [Related]
20. A pilot study of mifepristone and misoprostol administered at the same time for abortion up to 49 days gestation.
Murthy AS; Creinin MD; Harwood B; Schreiber C
Contraception; 2005 May; 71(5):333-6. PubMed ID: 15854632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
